<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01582893</url>
  </required_header>
  <id_info>
    <org_study_id>1492</org_study_id>
    <secondary_id>CIV-11-10-002741</secondary_id>
    <nct_id>NCT01582893</nct_id>
  </id_info>
  <brief_title>Permeability Enhancement to Reduce Chronic Inflammation</brief_title>
  <acronym>PERCI</acronym>
  <official_title>Permeability Enhancement to Reduce Chronic Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gambro Dialysatoren GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Baxter Healthcare Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic dialysis patients with end stage renal disease have an increased mortality rate as
      compared to the age matched healthy population. It is known that chronic inflammation
      contributes to the high incidence of cardiovascular events in chronic dialysis patients.
      Dialyzers made by membranes with increased pore size (high cut-off Dialyzer HCO1100) may be
      beneficial in the elimination of inflammatory mediators and may improve the inflammatory
      status. Hypothesis: In this study it will be investigated whether the treatment with HCO1100
      will improve the inflammatory status of chronic dialysis patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of CD162 expression on monocytes</measure>
    <time_frame>8 weeks (3 weeks treatment phase, 2 weeks wash out phase, 3 weeks treatment phase)</time_frame>
    <description>change of CD162 expression on monocytes, timepoints in each treatment phase: 1.)1st.day (prae dialysis) 2.)1st.day (post dialysis) 3.)2nd.day (prae dialysis) 4.)8th.day (prae dialysis) 5.)15th.day (prae dialysis) 6.)22nd.day (prae dialysis)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Albumin blood level</measure>
    <time_frame>8 weeks (3 weeks treatment phase, 2 weeks wash out phase, 3 weeks treatment phase)</time_frame>
    <description>change of albumin blood level, timepoints in each treatment phase: 1.)1st.day (prae dialysis) 2.)1st.day (post dialysis) 3.)2nd.day (prae dialysis) 4.)8th.day (prae dialysis) 5.)15th.day (prae dialysis) 6.)22nd.day (prae dialysis)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>End Stage Renal Disease</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>HCO1100-P14L</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HCO1100 is connected in row with low flux dialyzer P14L</description>
  </arm_group>
  <arm_group>
    <arm_group_label>P210H</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High flux Filter P210H</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HCO1100</intervention_name>
    <description>Dialysis</description>
    <arm_group_label>HCO1100-P14L</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>P210H</intervention_name>
    <description>Dialysis</description>
    <arm_group_label>P210H</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dialysis treatment for ≥ 3 months

          -  Dialysis 3x weekly

          -  Vascular access by fistula or CVC providing QB of ≥ 250 ml/min

          -  Dialysis with high-flux dialyzer for a minimum of 2 weeks before begin of study

          -  CRP &gt; 5mg/L at least once within 12 weeks before inclusion

          -  Age &gt; 18 and &lt; 99 Years

          -  Ability to give written informed consent

        Exclusion Criteria:

          -  Missing informed consent form

          -  Clinically manifested infection or current CRP-value &gt; 50mg/L

          -  Serum albumin &lt; 35g/L

          -  Intake of immune suppressive medication

          -  Pregnancy or lactation

          -  Participation in a different study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Girndt, MD</last_name>
    <role>Study Director</role>
    <affiliation>Martin-Luther-Universität Halle-Wittenberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ralf Schindler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charité, Humboldt Universität Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>KfH Bachstzelzenweg 4</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Sachsen-Anhalt</state>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KfH-Bismarkstrasse 95-96</name>
      <address>
        <city>Berlin</city>
        <zip>10625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2012</study_first_submitted>
  <study_first_submitted_qc>April 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2012</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inflammation</keyword>
  <keyword>dialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

